about
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsSoluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV diseaseThe CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recoveryAn updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopeniaHospital admissions for HIV-infected prisoners in Italy.Neurocognitive effects of HIV, hepatitis C, and substance use historyIn vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.When to start antiretroviral therapyInterleukin-2 therapy in patients with HIV infection.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionThe consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.Evolving character of chronic central nervous system HIV infection.Immunity to HIV in Early LifeComparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.Challenges in HIV Vaccine Research for Treatment and Prevention.HIV infection, inflammation, immunosenescence, and aging.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infectionAntiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions.Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort studyCorneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study.Immunologic basis of cardiovascular disease in HIV-infected adults.Towards an HIV cure: a global scientific strategyThe effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrationsA prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapyRelationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals.Cardiovascular implications from untreated human immunodeficiency virus infection.Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkersAn internationally generalizable risk index for mortality after one year of antiretroviral therapy.Appreciating Reasons for Nonadherence in Women.HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathwaysDeath rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational studyPotential health impacts of heavy metals on HIV-infected population in USADevelopment of diagnostic criteria for serious non-AIDS events in HIV clinical trials.
P2860
Q24656950-E3132A55-AB1C-4B38-98BD-948E67021847Q27021524-86638E3B-2168-4334-8CAA-81926875FCD0Q27690715-300D7326-0ACA-464B-8A8B-CA0235590FD2Q28731034-2AC466A8-C66B-4B28-993A-3EBEBB7463B0Q29307877-B6963A7F-3BBB-473C-AD1A-EFFD25A4AC86Q30934548-7F82F102-9F6E-49AE-B727-E9BE523A1E5DQ33393202-240A70B1-FFD3-4082-9B07-05A9A8B329BFQ33442442-545A1F8A-4100-4C89-AC60-C34C8AE662F8Q33652957-755953DA-11C9-4DFF-8BBB-AD8AB9EC98C8Q33749579-242469D1-7DC9-445C-89A8-092CA42DFB0BQ33799012-F4F12EFB-948C-43D6-85DC-D364469AA9D1Q33847543-2699DA87-433F-4DCA-A297-42F725075439Q33857515-40142131-30F3-4AC6-9AB2-EE2C4B2F7817Q33889580-6A550F9A-C88C-427A-B589-D2461D48E6FBQ33962303-32C161EB-1587-41FA-88AF-4DE2DD9DB7FCQ33987654-AE2261B1-4E16-4F1D-8A24-C4F9EF29465CQ33995713-A976BA72-E9A3-4CED-BB36-929E44BF25A9Q34033051-4545597C-97E9-468C-85F2-C66770E6737CQ34083315-5E3B9CE6-199C-4EAE-91C3-177F967B4257Q34148683-C302BE2F-B4A0-48EE-ABF0-EE925E493704Q34150710-008C9021-3BEB-438D-9AE6-0E689B7E7DB0Q34351320-D44FB965-799A-4100-920B-C29B81F2300CQ34395892-FC218032-9241-40E6-B440-639536FB2C46Q34396067-99D009F6-F1EE-4A23-AFB6-B06FCE4EA7A7Q34510410-C0602347-4097-43BC-B11E-62344DB6320DQ34554118-3A557F9D-268D-48AA-832A-43401317108FQ34608563-B9598204-2EBA-485A-8AAA-A94CCC253CBDQ34638205-B6BC4EF9-669F-4438-AD70-942AAD276D8FQ34640562-17D11A8A-14E4-4B52-BA50-D7D4504D501FQ34693341-B9FA6D3D-4B3A-4E88-AC6D-A6858849306CQ34756452-7AEDDF30-344A-44E2-8DDD-D09C4EB9CC45Q34781765-26E6C32B-53C3-407E-90BE-3ED0D1CC29DFQ34793193-8DBE544C-8B16-4992-8F03-18A0208ADF86Q34802684-ACB88DA9-A663-43FC-9696-B32E02C4BF57Q34813110-1235FB43-3DE2-428A-AA52-49A09CF01AC4Q34861775-4A0F98DB-3CA4-4DEF-A90E-FF8DD4ECFEDCQ34889163-6D50A5C3-CF27-4728-8AF1-E2AF1544D842Q34903835-3149CF9F-14AA-48CB-9B3A-7D034CEF909FQ34984653-E0A93142-254E-4325-AF61-7B7B723FCEACQ35030752-27BDAD63-D0EC-45CA-BA0B-07B364CE9473
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The role of HIV in serious diseases other than AIDS.
@en
The role of HIV in serious diseases other than AIDS.
@nl
type
label
The role of HIV in serious diseases other than AIDS.
@en
The role of HIV in serious diseases other than AIDS.
@nl
prefLabel
The role of HIV in serious diseases other than AIDS.
@en
The role of HIV in serious diseases other than AIDS.
@nl
P2860
P1433
P1476
The role of HIV in serious diseases other than AIDS.
@en
P2093
Andrew N Phillips
James Neaton
P2860
P304
P356
10.1097/QAD.0B013E3283174636
P407
P577
2008-11-01T00:00:00Z